Back
DBV Technologies SA Vs. Akari Therapeutics PLC Industry Stock Comparison
Sell
34
DBVT
DBV Technologies SA
Last Price:
0.75
Seasonality Move:
-22.7%
Buy
58
AKTX
Akari Therapeutics PLC
Last Price:
3.10
Seasonality Move:
-14.85%
Sell
34
DBV Technologies SA (DBVT)
is a Sell
Is DBV Technologies SA a Buy, Sell or Hold?
- The current DBV Technologies SA [DBVT] share price is $0.75. The Score for DBVT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- DBVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $3.22. The Score for AKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- AKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DBVT Stock Price Chart
What is DBV Technologies SA's stock price today?
-
The DBV Technologies SA share price today is $0.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing slight buying pressure.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $3.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
DBVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 36.81 | Sell |
| Chaikin Money Flow: | 35473 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.75 - 0.91) | Sell |
| Bollinger Bands (100): | (0.8 - 1.14) | Sell |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 42.71 | Sell |
| Chaikin Money Flow: | 617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.27 - 3.73) | Sell |
| Bollinger Bands (100): | (2.08 - 3.8) | Buy |
DBVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.74 | Buy |
| 20-day SMA: | 0.81 | Sell |
| 50-day SMA: | 0.87 | Sell |
| 200-day SMA: | 1.31 | Sell |
| 8-day EMA: | 0.75 | Sell |
| 20-day EMA: | 0.79 | Sell |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 1.35 | Sell |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.27 | Sell |
| 20-day SMA: | 3.48 | Sell |
| 50-day SMA: | 3.6 | Sell |
| 200-day SMA: | 2.61 | Buy |
| 8-day EMA: | 3.26 | Sell |
| 20-day EMA: | 3.39 | Sell |
| 50-day EMA: | 3.37 | Sell |
| 200-day EMA: | 3.18 | Buy |
DBV Technologies SA Earnings Growth & DBVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and a decrease next year of $0.55 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
DBV Technologies SA Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics PLC Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||